Stephen N Makoni MD

Oncology•Atlantis, FL

Physician

Join to View Full Profile

3450 Lantana RdSte 100Atlantis, FL 33462
Phone+1 561-965-1864
Fax+1 561-967-5005

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
Mercy Catholic Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Zimbabwe Huggins SOMClass of 1991

Certifications & Licensure

FL State Medical License 2016 - 2027
KY State Medical License 2003 - 2020
ND State Medical License 2006 - 2019
OH State Medical License 2006 - 2014
PA State Medical License 2001 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
ACTIVE_NOT_RECRUITING
PHASE3
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
ACTIVE_NOT_RECRUITING
PHASE3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
ACTIVE_NOT_RECRUITING
PHASE3
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
ACTIVE_NOT_RECRUITING
PHASE3
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

3 citations
The impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.
Jessica A. Maxwell, Oleg Shats, Joshua Aldridge, Elizabeth Lyden, Amy Krie
The Breast Journal. 2019-09-01
80 citations
Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Abdullah Yalcin, Brian F. Clem, S Makoni, Amy L. Clem, Kristin K. Nelson
Oncogene. 2010-01-07
24 citations
Clinical spectrum of myelophthisis in cancer patients.
Stephen N. Makoni, Damian A. Laber
American Journal of Hematology. 2004-05-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Stephen N Makoni MD

Dr. Makoni is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.